» Articles » PMID: 31761610

Risk Factors and Reasons for Reoperation After Radical Cystectomy

Overview
Journal Urol Oncol
Publisher Elsevier
Date 2019 Nov 26
PMID 31761610
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Reoperation after radical cystectomy (RC) is common but the types of reoperation after RC and associated risk factors have not been fully characterized. Here, we provide a detailed, contemporary account of the factors that drive surgical reoperation within the first 30-days after surgery, identify at risk patient populations, and describe common reoperations.

Materials And Methods: The American College of Surgeons National Surgical Quality Improvement Program database (2012-2017) was analyzed to identify 30-day reoperation rates after RC. Captured variables included demographic, preoperative, operative, and postoperative characteristics. Postoperative characteristics included complications, including types of reoperation, length of stay, unplanned readmissions, and discharge destination. Pearson chi-squared and multivariable logistic regression models were used for analysis.

Results: A total of 10,848 patients underwent RC and there were 633 (5.84%) unplanned reoperations. On multivariable logistic regression, patient factors associated with increased risk of reoperation included longer operative times at index procedure (>90th percentile operative time) (OR1.41 [1.08-1.83], P = 0.02), smoking (OR1.34 [1.11-1.63], P < 0.01), obesity (BMI≥30) (OR 1.29 [1.04-1.60], P = 0.02) and chronic obstructive pulmonary disease (OR1.74 [1.36-2.3], P < 0.01). Other significant factors included clinically significant hypertension, perioperative blood transfusion, and male sex. The most common reoperation procedures were those performed on the gastrointestinal tract, accounting for 60.59% (349) of all reoperations, followed by skin/subcutaneous procedures 14.76% (85), followed by Genitourinary procedures at 8.16% (47). Patients who underwent reoperation were at higher risk for readmission, discharge to a facility, and death (P < 0.01).

Conclusion: Reoperation after RC is associated with approximately 5% rate of reoperation within 30 days of surgery. The most common reason for reoperation was related to the gastrointestinal tract, accounting for more than 60% of all reoperations. Risk factors for reoperation included longer surgical times, smoking, obesity, chronic obstructive pulmonary disease, perioperative blood transfusion, and clinically significant hypertension. Knowledge of these factors can aid in operative planning and counseling and lead to possible strategies to reduce reoperations in the early perioperative setting.

Citing Articles

Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database.

Choi J, Lee J, Hwang Y, Jeong B, Lee S, Ku J Sci Rep. 2024; 14(1):10550.

PMID: 38719836 PMC: 11078966. DOI: 10.1038/s41598-024-61005-6.


A Procedure and Complication-Specific Assessment of Smoking in Aesthetic Surgery: A Systematic Review and Meta-Analysis.

Bouhadana G, ElHawary H, Alam P, Gilardino M Plast Surg (Oakv). 2024; 32(1):115-126.

PMID: 38433792 PMC: 10902487. DOI: 10.1177/22925503221085083.


Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration.

Naha U, Khurshudyan A, Vigneswaran H, Mima M, Abern M, Moreira D Transl Androl Urol. 2023; 12(11):1631-1637.

PMID: 38106684 PMC: 10719775. DOI: 10.21037/tau-23-266.


A retrospective analysis of the factors associated with increased risk of readmission within 30 days after primary transurethral resection of bladder tumor.

Jindal T, Sarwal A, Jain P, Koju R, Mukherjee S Curr Urol. 2023; 17(4):257-261.

PMID: 37994339 PMC: 10662801. DOI: 10.1097/CU9.0000000000000160.


Association of smoking history on health-related quality of life in patients undergoing radical cystecomy.

Beech B, Doudt A, Sjoberg D, Clements M, Tin A, Atkinson T Urol Oncol. 2023; 41(7):325.e9-325.e14.

PMID: 36631370 PMC: 10272017. DOI: 10.1016/j.urolonc.2022.12.009.